Results
AIM ImmunoTech Inc.
03/06/2026 | Press release | Distributed by Public on 03/06/2026 16:16
Material Agreement, Corporate Action (Form 8-K)
Item 1.01 Entry into a Material Definitive Agreement.
Warrant Agency Agreement
On March 6, 2026, in connection with the closing of its previously announced Rights Offering (defined below), AIM ImmunoTech Inc. (the "Company") entered into a Warrant Agency Agreement with Equiniti Trust Company, LLC ("EQ"), pursuant to which EQ agreed to act as warrant agent with respect to warrants included in the units issued by the Company in the Rights Offering. A copy of the Warrant Agency Agreement is filed as Exhibit 10.1 to this report and is incorporated by reference herein.
Item 3.03 Material Modification to Rights of Security Holders.
The disclosure contained in Item 5.03 of this report is incorporated by reference herein.
AIM ImmunoTech Inc. published this content on March 06, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 06, 2026 at 22:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]